Author

Debra Odink

OpenAlex ID: A5067525435

A novel serum glucocorticoid regulated kinase 1 inhibitor improves cardiac structure and function in heart failure

2025 · Eric Campeau, Sabindra Pradhananga, et al. · Research Square · 1

Genetic, Preclinical, and Clinical Evidence Supports SGK1 Inhibition in Heart Failure

2026 · Sabindra Pradhananga, Dinesh Srinivasan, et al. · JACC Heart Failure

Abstract Wed159: A Potent Serum and Glucocorticoid-Regulated Kinase 1 (SGK1) Inhibitor is Protective in a Model of CKMD

2026 · Eric Campeau, Sabindra Pradhananga, et al. · Circulation Research

Abstract 4369238: THRV-1268, a potent and selective serum and glucocorticoid regulated kinase (SGK1) inhibitor, improves adverse cardiac remodeling better than Jardiance® (empagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor in heart failure

2025 · Sabindra Pradhananga, William Salvail, et al. · Circulation

Abstract 4369927: The serum and glucocorticoid regulated kinase 1 (SGK1) inhibitor THRV-1268 attenuates hallmarks of heart failure by reducing inflammation and fibrosis beyond sodium/glucose cotransporter 2 inhibition

2025 · Eric Campeau, Sabindra Pradhananga, et al. · Circulation

Abstract 4369991: Small molecule inhibitors of serum glucocorticoid kinase 1 (SGK1) prevent cardiac structural and functional decline induced in a transverse aortic constriction (TAC) model

2025 · Dinesh Srinivasan, Sabindra Pradhananga, et al. · Circulation

Abstract 4147456: Serum and Glucocorticoid Regulated Kinase 1 (SGK1) Inhibition Induces Anti-Fibrotic and Anti-Inflammatory Responses: Relevance to Cardiac Fibrosis

2024 · Delphine Labit, Maroua Khalifa, et al. · Circulation

Abstract P4-08-21: Development of novel inhibitors of the serum/glucocorticoid induced kinase (SGK) family to address limitations of AKT/PI3K/mTOR inhibitors in breast cancer

2023 · Delphine Labit, Sabindra Pradhananga, et al. · Cancer Research

Works count: 8

Citation count: 1

H-index: 1

I10-index: